Literature DB >> 478642

Enhancement of generation of monocyte tissue thromboplastin by bacterial phagocytosis: possible pathway for fibrin formation on infected vegetations in bacterial endocarditis.

C J van Ginkel, L Thörig, J Thompson, J I Oh, W G van Aken.   

Abstract

The deposition of fibrin on infected vegetations and the presence of mononuclear phagocytes that have phagocytized bacteria are remarkabe features in experimental bacterial endocarditis. In a study in vitro, we show that phagocytosis of bacteria by human monocytes enhances thromboplastin generation by these cells. Maximal enhancement of the generation of thromboplastin by monocytes was about six times compared with that in the control experiment without bacteria, and it was obtained by preincubation of the monocytes with 5 to 10 bacteria per monocyte. No quantitative difference was observed between Staphylococcus epidermidis and Streptococcus sanguis as to the enhancement of the monocyte thromboplastin generation. An enhancement of the procoagulant activity generation was also observed after addition of bacteria to human or rabbit whole blood. Probably, this generation was also due to synthesis of thromboplastin by monocytes. It is conceivable that fibrin deposition on infected vegetations during bacterial endocarditis is mediated by thromboplastin synthesis by monocytes.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 478642      PMCID: PMC414463          DOI: 10.1128/iai.25.1.388-395.1979

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  15 in total

1.  Metalloenzymes and myocardial infarction. II. Malic and lactic dehydrogenase activities and zinc concentrations in serum.

Authors:  D D ULMER; B L VALLEE; W E WACKER
Journal:  N Engl J Med       Date:  1956-09-06       Impact factor: 91.245

2.  Leukocyte procoagulant activity: enhancement of production in vitro by IgG and antigen-antibody complexes.

Authors:  H Rothberger; T S Zimmerman; H L Spiegelberg; J H Vaughan
Journal:  J Clin Invest       Date:  1977-03       Impact factor: 14.808

3.  Effect of warfarin on the induction and course of experimental Staphylococcus epidermidis endocarditis.

Authors:  L Thörig; J Thompson; F Eulderink
Journal:  Infect Immun       Date:  1977-09       Impact factor: 3.441

4.  Size distribution, electronic recognition, and counting of human blood monocytes.

Authors:  H Loos; B Blok-Schut; B Kipp; R van Doorn; L Meerhof
Journal:  Blood       Date:  1976-11       Impact factor: 22.113

5.  Further link between complement activation and blood coagulation.

Authors:  H Prydz; A C Allison; H U Schorlemmer
Journal:  Nature       Date:  1977-11-10       Impact factor: 49.962

6.  Stimulation of monocyte procoagulant activity by adherence to different surfaces.

Authors:  C J van Ginkel; W G van Aken; J I Oh; J Vreeken
Journal:  Br J Haematol       Date:  1977-09       Impact factor: 6.998

7.  Macrophages synthesis and release prostaglandins in response to inflammatory stimuli.

Authors:  J L Humes; R J Bonney; L Pelus; M E Dahlgren; S J Sadowski; F A Kuehl; P Davies
Journal:  Nature       Date:  1977-09-08       Impact factor: 49.962

8.  Effect of warfarin on the induction and course of experimental endocarditis.

Authors:  J Thompson; F Eulderink; H Lemkes; R van Furth
Journal:  Infect Immun       Date:  1976-12       Impact factor: 3.441

9.  Bacterial adherence in the pathogenesis of endocarditis. Interaction of bacterial dextran, platelets, and fibrin.

Authors:  W M Scheld; J A Valone; M A Sande
Journal:  J Clin Invest       Date:  1978-05       Impact factor: 14.808

10.  Prostaglandin E production by human blood monocytes and mouse peritoneal macrophages.

Authors:  J I Kurland; R Bockman
Journal:  J Exp Med       Date:  1978-03-01       Impact factor: 14.307

View more
  14 in total

1.  Role of adherence in infective endocarditis.

Authors:  M A Kielhofner; R J Hamill
Journal:  Tex Heart Inst J       Date:  1989

2.  Platelet-activating factor modulates endotoxin-induced macrophage procoagulant activity by a protein kinase C-dependent mechanism.

Authors:  D S Kucey; P Y Cheung; O D Rotstein
Journal:  Infect Immun       Date:  1992-03       Impact factor: 3.441

3.  Effects of interleukin-1, lipopolysaccharide, and streptococci on procoagulant activity of cultured human cardiac valve endothelial and stromal cells.

Authors:  T A Drake; M Pang
Journal:  Infect Immun       Date:  1989-02       Impact factor: 3.441

4.  Legionella pneumophila and related organisms induce the generation of procoagulant activity by peripheral mononuclear cells in vitro.

Authors:  G Miragliotta; N Semeraro; L Marcuccio; D Fumarola
Journal:  Infection       Date:  1982       Impact factor: 3.553

5.  Effects of monocytopenia and anticoagulation in experimental Streptococcus sanguis endocarditis.

Authors:  L Thörig; J Thompson; F Eulderink; J J Emeis; R Van Furth
Journal:  Br J Exp Pathol       Date:  1980-02

6.  Tissue factor is a major stimulus for vegetation formation in enterococcal endocarditis in rabbits.

Authors:  T A Drake; G M Rodgers; M A Sande
Journal:  J Clin Invest       Date:  1984-06       Impact factor: 14.808

7.  Stimulation of monocyte tissue factor expression in an in vitro model of bacterial endocarditis.

Authors:  M J Bancsi; J Thompson; R M Bertina
Journal:  Infect Immun       Date:  1994-12       Impact factor: 3.441

8.  Role of granulocytes in experimental Streptococcus sanguis endocarditis.

Authors:  M J Meddens; J Thompson; F Eulderink; W C Bauer; H Mattie; R van Furth
Journal:  Infect Immun       Date:  1982-04       Impact factor: 3.441

9.  The role of bacterial adherence in the pathogenesis of infective endocarditis.

Authors:  J Thompson; M J Meddens; L Thörig; R van Furth
Journal:  Infection       Date:  1982       Impact factor: 3.553

10.  Role of granulocytes and monocytes in experimental Staphylococcus epidermidis endocarditis.

Authors:  M J Meddens; J Thompson; W C Bauer; J Hermans; R van Furth
Journal:  Infect Immun       Date:  1983-07       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.